表紙
市場調查報告書

全球結核診斷及治療市場調查與預測

Global Tuberculosis Diagnosis and Treatment Market 2019-2025

出版商 Orion Market Research Pvt Ltd 商品編碼 599602
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
Back to Top
全球結核診斷及治療市場調查與預測 Global Tuberculosis Diagnosis and Treatment Market 2019-2025
出版日期: 2019年10月10日內容資訊: 英文
簡介

本報告提供全球結核診斷及治療市場相關調查,彙整市場規模和藥物,診斷,各終端用戶,地區別趨勢,及打入市場的主要企業的簡介等資料。

第1章 報告的摘要

第2章 市場概要與趨勢

  • 定義
  • 分析師的見解及目前市場趨勢
  • 法律規章

第3章 市場決策因素

  • 促進要素
  • 阻礙要素
  • 機會

第4章 市場區隔

  • 藥物別
    • 一線藥物
    • 二線藥物
    • IRRATIONAL蛋白設計
  • 診斷別
    • 實驗室檢驗
    • 核酸檢驗
    • 結核菌素反應
    • 造影
    • 藥物敏感性檢驗
    • 其他
  • 各終端用戶
    • 醫院
    • 政府機關
    • 個人
    • 其他

第5章 競爭環境

  • 主要策略
  • 主要企業分析

第6章 各地區分析

  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第7章 企業簡介

  • ABBOTT LABORATORIES
  • AKONNI BIOSYSTEMS, INC.
  • ALERE, INC.
  • BECTON DICKINSON AND CO.
  • BIO - SYNTH INC.
  • BIOMERIEUX SA
  • CEPHEID INC
  • EIKEN CHEMICAL CO. LTD.
  • EPISTEM HOLDINGS PLC
  • F. HOFFMANN-LA ROCHE AG
  • HAIN LIFESCIENCES GMBH
  • HOLOGIC CORPORATION
  • GLAXOSMITHKLINE
  • LABATEC PHARMA SA
  • LUPIN
  • OTSUKA NOVEL PRODUCTS GMBH
  • QIAGEN
  • SANDOZ
  • SANOFI
  • THERMO FISHER SCIENTIFIC, INC

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: OMR2019918

Title:
Global Tuberculosis Diagnosis and Treatment
Market Size, Share & Trends Analysis Report, By Diagnosis (Laboratory Testing, Nucleic Acid Tests, Radiography, Drug Susceptibility Test, and Other Tests),B Drugs (First Line Drugs and Second Line Drugs), By End-User (Hospitals & Clinics, Government & Non-Government Organizations, and Others), and Forecast 2019-2025.

The global tuberculosis diagnosis and treatment market is expected to grow at a significant rate during 2019-2025. Tuberculosis is one of the top 10 causes of global fatalities as it affects the lungs and causes life-threatening conditions in the human body. The market growth is attributed to the rising incidence of drug-susceptible (DS) tuberculosis (TB), an increase in multi-drug resistant (MDR) TB cases and increasing R&D for the development of tuberculosis drugs. In addition, robust product pipeline for the tuberculosis products and increasing initiatives by the government in emerging economies for the treatment of tuberculosis creates an ample opportunity for the growth of the market in the near future.

The global tuberculosis diagnosis and treatment market are segmented on the basis of diagnosis, drugs, and end-user. Based on the diagnosis, the market is segmented into laboratory testing, nucleic acid tests, radiography, drug susceptibility test, and other tests. Laboratory testing for tuberculosis diagnosis is expected to hold a significant share in the market owing to advancements in culture-based tests. Further, on the basis of drugs, the market is bifurcated into first-line drugs such as Pyrazinamide (Z/PZA), Ethambutol (E/EMB), Rifabutin (RFB), and Streptomycin; and second-line drugs such as Kanamycin (KM), Amikacin (AMK), and Capreomycin (CM). Based on the end-user, the market is segmented into hospitals & clinics, government & non-government organizations, and others. Hospitals & clinics are expected to contribute a major share in the market.

Geographically, the market study of the global tuberculosis diagnosis and treatment market report covers the analysis of four major region including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and Rest of the World (RoW). Increasing prevalence of tuberculosis across the globe is expected to give a boost to the growth of the market. Further, the market study covers the analysis of several players operating in the market. Some of the key players operating in the market include Abbott Laboratories, Inc., F. Hoffmann La Roche AG, Beckton, Dickinson, and Co., Otsuka Pharmaceuticals Co. Ltd., Johnson & Johnson Services, Inc., and Novartis AG.

Research Methodology

The market study of the global tuberculosis diagnosis and treatment is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for tuberculosis drug manufacturers, suppliers, traders, and third-party distributors, pharmaceutical contract manufacturers, medical device companies, investing companies and potential investors, government organizations and research institutes, regulatory agencies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size and market growth opportunities. The report will serve as a source for a 360-degree analysis of the market delivering insights into the market for making better business decisions.

Market Segmentation

  • 1. Global Tuberculosis Diagnosis and Treatment Market Research and Analysis by Diagnosis.
  • 2. Global Tuberculosis Diagnosis and Treatment Market Research and Analysis by Drugs.
  • 3. Global Tuberculosis Diagnosis and Treatment Market Research and Analysis by End-User.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Otsuka Pharmaceuticals Co. Ltd.
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Johnson & Johnson Services Inc.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Abbott Laboratories, Inc.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Becton, Dickinson and Co.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Thermo Fisher Scientific, Inc.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Tuberculosis Diagnosis and Treatment Market by Diagnosis
    • 5.1.1. Laboratory Testing
    • 5.1.2. Nucleic Acid Tests
    • 5.1.3. Radiography
    • 5.1.4. Drug Susceptibility Test
    • 5.1.5. Other Tests
  • 5.2. Global Tuberculosis Diagnosis and Treatment Market by Drugs
    • 5.2.1. First Line Drugs
    • 5.2.2. Second Line Drugs
  • 5.3. Global Tuberculosis Diagnosis and Treatment Market by End-User
    • 5.3.1. Hospitals & Clinics
    • 5.3.2. Government & Non-Government Organizations
    • 5.3.3. Others

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. US
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories Inc.
  • 7.2. Akonni Biosystems, Inc.
  • 7.3. Alere, Inc.
  • 7.4. Becton Dickinson and Co.
  • 7.5. Biochemical and Synthetic Products Pvt Ltd
  • 7.6. Biomerieux SA
  • 7.7. Cepheid Inc.
  • 7.8. Eiken Chemical Co. Ltd.
  • 7.9. Epistem Ltd.
  • 7.10. F. Hoffmann-LA Roche AG
  • 7.11. GlaxoSmithKline PLC
  • 7.12. Hain Lifescience GmbH
  • 7.13. Hologic Inc.
  • 7.14. Johnson & Johnson Services, Inc.
  • 7.15. Labatec Pharma SA
  • 7.16. Lupin Pharmaceuticals Inc.
  • 7.17. Novartis AG
  • 7.18. Otsuka Pharmaceutical Co. Ltd.
  • 7.19. PerkinElmer Inc.
  • 7.20. Qiagen GmbH
  • 7.21. Sanofi SA

Thermo Fisher Scientific, Inc.

LIST OF TABLES

  • GLOBAL TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)
  • GLOBAL LABORATORY TESTINGFOR TUBERCULOSIS DIAGNOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL NUCLEIC ACID TESTSFOR TUBERCULOSIS DIAGNOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL RADIOGRAPHYFOR TUBERCULOSIS DIAGNOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL DRUG SUSCEPTIBILITY TESTFOR TUBERCULOSIS DIAGNOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL OTHER TESTSFOR TUBERCULOSIS DIAGNOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DRUGS, 2018-2025 ($ MILLION)
  • GLOBAL FIRST LINE DRUGSFOR TUBERCULOSIS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL SECOND LINE DRUGSFOR TUBERCULOSIS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • GLOBAL HOSPITALS& CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL GOVERNMENT & NON-GOVERNMENT ORGANIZATIONSMARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL OTHER END-USERSMARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • NORTH AMERICANTUBERCULOSIS DIAGNOSIS AND TREATMENTMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • NORTH AMERICANTUBERCULOSIS DIAGNOSIS AND TREATMENTMARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)
  • NORTH AMERICAN TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DRUGS, 2018-2025 ($ MILLION)
  • NORTH AMERICAN TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • EUROPEANTUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • EUROPEAN TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)
  • EUROPEAN TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DRUGS, 2018-2025 ($ MILLION)
  • EUROPEAN TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • ASIA-PACIFICTUBERCULOSIS DIAGNOSIS AND TREATMENTMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • ASIA-PACIFIC TUBERCULOSIS DIAGNOSIS AND TREATMENTMARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)
  • ASIA-PACIFIC TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DRUGS, 2018-2025 ($ MILLION)
  • ASIA-PACIFIC TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • REST OF THE WORLD TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)
  • REST OF THE WORLD TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DRUGS, 2018-2025 ($ MILLION)
  • REST OF THE WORLD TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

LIST OF FIGURES

  • GLOBAL TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)
  • GLOBAL LABORATORY TESTINGFOR TUBERCULOSIS DIAGNOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL NUCLEIC ACID TESTSFOR TUBERCULOSIS DIAGNOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL RADIOGRAPHYFOR TUBERCULOSIS DIAGNOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL DRUG SUSCEPTIBILITY TESTFOR TUBERCULOSIS DIAGNOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL OTHER TESTSFOR TUBERCULOSIS DIAGNOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DRUGS, 2018-2025 ($ MILLION)
  • GLOBAL FIRST LINE DRUGSFOR TUBERCULOSIS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL SECOND LINE DRUGSFOR TUBERCULOSIS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • GLOBAL HOSPITALS& CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL GOVERNMENT & NON-GOVERNMENT ORGANIZATIONSMARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL OTHER END-USERSMARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • NORTH AMERICANTUBERCULOSIS DIAGNOSIS AND TREATMENTMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • NORTH AMERICANTUBERCULOSIS DIAGNOSIS AND TREATMENTMARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)
  • NORTH AMERICAN TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DRUGS, 2018-2025 ($ MILLION)
  • NORTH AMERICAN TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • EUROPEANTUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • EUROPEAN TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)
  • EUROPEAN TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DRUGS, 2018-2025 ($ MILLION)
  • EUROPEAN TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • ASIA-PACIFICTUBERCULOSIS DIAGNOSIS AND TREATMENTMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • ASIA-PACIFIC TUBERCULOSIS DIAGNOSIS AND TREATMENTMARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)
  • ASIA-PACIFIC TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DRUGS, 2018-2025 ($ MILLION)
  • ASIA-PACIFIC TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • REST OF THE WORLD TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)
  • REST OF THE WORLD TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DRUGS, 2018-2025 ($ MILLION)
  • REST OF THE WORLD TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
Back to Top